35 results on '"McIntyre, Rebecca"'
Search Results
2. Changes and differences in school food standards (2010–2021) and free school meal provision during COVID‐19 across the UK: Potential implications for children's diets.
- Author
-
McIntyre, Rebecca Louise, Adamson, Ashley J, Nelson, Michael, Woodside, Jayne, Beattie, Shirley, and Spence, Suzanne
- Subjects
- *
SCHOOL health services , *COVID-19 , *CHILD nutrition , *FOOD security , *NUTRITIONAL requirements , *SCHOOLS , *FOOD service , *NUTRITION policy , *MEALS - Abstract
This paper explores changes to school food standards from 2010, free school meal provision during the COVID‐19 pandemic across the UK and potential implications for children's diets. To obtain information on UK school food policies and free school meal provision methods we reviewed several sources including news articles, policy documents and journal articles. School food is an important part of the UK's health agenda and commitment to improving children's diets. Each UK nation has food‐based standards implemented, however, only Scotland and Wales also have nutrient‐based standards. School food standards in each nation have been updated in the last decade. Universal free school meals are available for children in the first 3 years of primary school in England and the first 5 years of primary school in Scotland, with plans announced for implementation of free school meals for all primary schoolchildren in Scotland and Wales. There is a lack of consistent monitoring of school food across the UK nations, and a lack of reporting compliance to the standards. Each nation differed in its response and management of free school meals during COVID‐related school closures. Further, there are issues surrounding the monitoring of the methods to provide free school meal support during school closures. The role of school food has been highlighted during COVID‐19, and with this, there have been calls for a review of free school meal eligibility criteria. The need for improved and consistent monitoring of school food across the UK remains, as does the need to evaluate the impact of school food on children's diets. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Inhibition of the neuromuscular acetylcholine receptor with atracurium activates FOXO/DAF‐16‐induced longevity.
- Author
-
McIntyre, Rebecca L., Denis, Simone W., Kamble, Rashmi, Molenaars, Marte, Petr, Michael, Schomakers, Bauke V., Rahman, Mizanur, Gupta, Siddhartha, Toth, Marton L., Vanapalli, Siva A., Jongejan, Aldo, Scheibye‐Knudsen, Morten, Houtkooper, Riekelt H., and Janssens, Georges E.
- Subjects
- *
LONGEVITY , *GENETIC engineering , *GENETIC databases , *CAENORHABDITIS elegans , *SUGAMMADEX , *MYONEURAL junction , *CHOLINERGIC receptors - Abstract
Transcriptome‐based drug screening is emerging as a powerful tool to identify geroprotective compounds to intervene in age‐related disease. We hypothesized that, by mimicking the transcriptional signature of the highly conserved longevity intervention of FOXO3 (daf‐16 in worms) overexpression, we could identify and repurpose compounds with similar downstream effects to increase longevity. Our in silico screen, utilizing the LINCS transcriptome database of genetic and compound interventions, identified several FDA‐approved compounds that activate FOXO downstream targets in mammalian cells. These included the neuromuscular blocker atracurium, which also robustly extends both lifespan and healthspan in Caenorhabditis elegans. This longevity is dependent on both daf‐16 signaling and inhibition of the neuromuscular acetylcholine receptor subunit unc‐38. We found unc‐38 RNAi to improve healthspan, lifespan, and stimulate DAF‐16 nuclear localization, similar to atracurium treatment. Finally, using RNA‐seq transcriptomics, we identify atracurium activation of DAF‐16 downstream effectors. Together, these data demonstrate the capacity to mimic genetic lifespan interventions with drugs, and in doing so, reveal that the neuromuscular acetylcholine receptor regulates the highly conserved FOXO/DAF‐16 longevity pathway. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
4. Repurposing nucleoside reverse transcriptase inhibitors (NRTIs) to slow aging.
- Author
-
Brochard, Thomas, McIntyre, Rebecca L., Houtkooper, Riekelt H., Seluanov, Andrei, Gorbunova, Vera, and Janssens, Georges E.
- Subjects
- *
NUCLEOSIDE reverse transcriptase inhibitors , *HIV , *AGING , *CELL communication , *ACTIVE aging - Abstract
Repurposing drugs already approved in the clinic to be used off-label as geroprotectors, compounds that combat mechanisms of aging, are a promising way to rapidly reduce age-related disease incidence in society. Several recent studies have found that a class of drugs—nucleoside reverse transcriptase inhibitors (NRTIs)—originally developed as treatments for cancers and human immunodeficiency virus (HIV) infection, could be repurposed to slow the aging process. Interestingly, these studies propose complementary mechanisms that target multiple hallmarks of aging. At the molecular level, NRTIs repress LINE-1 elements, reducing DNA damage, benefiting the hallmark of aging of 'Genomic Instability'. At the organellar level, NRTIs inhibit mitochondrial translation, activate ATF-4, suppress cytosolic translation, and extend lifespan in worms in a manner related to the 'Loss of Proteostasis' hallmark of aging. Meanwhile, at the cellular level, NRTIs inhibit the P2X7-mediated activation of the inflammasome, reducing inflammation and improving the hallmark of aging of 'Altered Intercellular Communication'. Future development of NRTIs for human aging health will need to balance out toxic side effects with the beneficial effects, which may occur in part through hormesis. • Nucleoside reverse transcriptase inhibitors (NRTIs) can be repurposed to slow aging. • NRTIs slow aging in mice by inhibiting retrotransposons and reducing DNA damage and inflammation. • NRTIs inhibit the P2X7-mediated activation of the inflammasome, reducing inflammaging. • NRTIs slow aging in worms by mito-hormesis and activation of ATF-4. • A correct NRTI dosing schemes may allow for NRTIs to be used in human aging studies. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Mitochondrial translation and dynamics synergistically extend lifespan in C. elegans through HLH-30.
- Author
-
Liu, Yasmine J., McIntyre, Rebecca L., Janssens, Georges E., Williams, Evan G., Lan, Jiayi, Weeghel, Michel van, Schomakers, Bauke, der Veen, Henk van, van der Wel, Nicole N., Yao, Pallas, Mair, William B., Aebersold, Ruedi, MacInnes, Alyson W., and Houtkooper, Riekelt H.
- Subjects
- *
CAENORHABDITIS elegans , *LYSOSOMES , *UNFOLDED protein response , *MITOCHONDRIA - Abstract
Mitochondrial form and function are closely interlinked in homeostasis and aging. Inhibiting mitochondrial translation is known to increase lifespan in C. elegans, and is accompanied by a fragmented mitochondrial network. However, whether this link between mitochondrial translation and morphology is causal in longevity remains uncharacterized. Here, we show in C. elegans that disrupting mitochondrial network homeostasis by blocking fission or fusion synergizes with reduced mitochondrial translation to prolong lifespan and stimulate stress response such as the mitochondrial unfolded protein response, UPRMT. Conversely, immobilizing the mitochondrial network through a simultaneous disruption of fission and fusion abrogates the lifespan increase induced by mitochondrial translation inhibition. Furthermore, we find that the synergistic effect of inhibiting both mitochondrial translation and dynamics on lifespan, despite stimulating UPRMT, does not require it. Instead, this lifespan-extending synergy is exclusively dependent on the lysosome biogenesis and autophagy transcription factor HLH-30/TFEB. Altogether, our study reveals the mechanistic crosstalk between mitochondrial translation, mitochondrial dynamics, and lysosomal signaling in regulating longevity. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
6. A Genome-Wide Association Study for Regulators of Micronucleus Formation in Mice.
- Author
-
McIntyre, Rebecca E., Nicod, Jérôme, Robles-Espinoza, Carla Daniela, Maciejowski, John, Na Cai, Hill, Jennifer, Verstraten, Ruth, Iyer, Vivek, Rust, Alistair G., Balmus, Gabriel, Mott, Richard, Flint, Jonathan, and Adams, David J.
- Subjects
- *
GENOMICS , *NUCLEOLUS , *LABORATORY mice - Abstract
In mammals the regulation of genomic instability plays a key role in tumor suppression and also controls genome plasticity, which is important for recombination during the processes of immunity and meiosis. Most studies to identify regulators of genomic instability have been performed in cells in culture or in systems that report on gross rearrangements of the genome, yet subtle differences in the level of genomic instability can contribute to whole organism phenotypes such as tumor predisposition. Here we performed a genome-wide association study in a population of 1379 outbred Crl:CFW(SW)-US_P08 mice to dissect the genetic landscape of micronucleus formation, a biomarker of chromosomal breaks, whole chromosome loss, and extranuclear DNA. Variation in micronucleus levels is a complex trait with a genomewide heritability of 53.1%. We identify seven loci influencing micronucleus formation (false discovery rate <5%), and define candidate genes at each locus. Intriguingly at several loci we find evidence for sexual dimorphism in micronucleus formation, with a locus on chromosome 11 being specific to males. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
7. Mouse models of colorectal cancer as preclinical models.
- Author
-
McIntyre, Rebecca E., Buczacki, Simon J.A., Arends, Mark J., and Adams, David J.
- Subjects
- *
LABORATORY mice , *COLON cancer , *BIOMARKERS , *NEOPLASTIC cell transformation , *SURGICAL excision - Abstract
In this review, we discuss the application of mouse models to the identification and pre-clinical validation of novel therapeutic targets in colorectal cancer, and to the search for early disease biomarkers. Large-scale genomic, transcriptomic and epigenomic profiling of colorectal carcinomas has led to the identification of many candidate genes whose direct contribution to tumourigenesis is yet to be defined; we discuss the utility of cross-species comparative 'omics-based approaches to this problem. We highlight recent progress in modelling late-stage disease using mice, and discuss ways in which mouse models could better recapitulate the complexity of human cancers to tackle the problem of therapeutic resistance and recurrence after surgical resection. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
8. Pharmaceutical and nutraceutical activation of FOXO3 for healthy longevity.
- Author
-
McIntyre, Rebecca L., Liu, Yasmine J., Hu, Man, Morris, Brian J., Willcox, Bradley J., Donlon, Timothy A., Houtkooper, Riekelt H., and Janssens, Georges E.
- Subjects
- *
LONGEVITY , *ACTIVE aging , *MUSCLE relaxants , *OLDER people , *METABOLITES , *LIFE expectancy , *AMP-activated protein kinases , *HISTONE deacetylase inhibitors - Abstract
Life expectancy has increased substantially over the last 150 years. Yet this means that now most people also spend a greater length of time suffering from various age-associated diseases. As such, delaying age-related functional decline and extending healthspan, the period of active older years free from disease and disability, is an overarching objective of current aging research. Geroprotectors, compounds that target pathways that causally influence aging, are increasingly recognized as a means to extend healthspan in the aging population. Meanwhile, FOXO3 has emerged as a geroprotective gene intricately involved in aging and healthspan. FOXO3 genetic variants are linked to human longevity, reduced disease risks, and even self-reported health. Therefore, identification of FOXO3-activating compounds represents one of the most direct candidate approaches to extending healthspan in aging humans. In this work, we review compounds that activate FOXO3, or influence healthspan or lifespan in a FOXO3-dependent manner. These compounds can be classified as pharmaceuticals, including PI3K/AKT inhibitors and AMPK activators, antidepressants and antipsychotics, muscle relaxants, and HDAC inhibitors, or as nutraceuticals, including primary metabolites involved in cell growth and sustenance, and secondary metabolites including extracts, polyphenols, terpenoids, and other purified natural compounds. The compounds documented here provide a basis and resource for further research and development, with the ultimate goal of promoting healthy longevity in humans. • FOXO3 is highly conserved and linked to longevity. • Activation of FOXO3 with geroprotectors is a strategy to extend longevity in humans. • A wide variety of pharmaceutical and nutraceutical compounds activate FOXO3. • Mechanisms of these compounds are diverse. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Genetic screens in mice for genome integrity maintenance and cancer predisposition.
- Author
-
Balmus, Gabriel and McIntyre, Rebecca E
- Subjects
- *
GENETIC testing , *LABORATORY mice , *GENOMES , *CANCER treatment , *DEVELOPMENTAL disabilities , *GENE regulatory networks , *GENETICS - Abstract
Genome instability is a feature of nearly all cancers and can be exploited for therapy. In addition, a growing number of genome maintenance genes have been associated with developmental disorders. Efforts to understand the role of genome instability in these processes will be greatly facilitated by a more comprehensive understanding of their genetic network. We highlight recent genetic screens in model organisms that have assisted in the discovery of novel regulators of genome stability and focus on the contribution of mice as a model organism to understanding the role of genome instability during embryonic development, tumour formation and cancer therapy. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
10. Disruption of Mouse Cenpj, a Regulator of Centriole Biogenesis, Phenocopies Seckel Syndrome.
- Author
-
McIntyre, Rebecca E., Chavali, Pavithra Lakshminarasimhan, Ismail, Ozama, Carragher, Damian M., Sanchez-Andrade, Gabriela, Forment, Josep V., Beiyuan Fu, Velasco-Herrera, Martin Del Castillo, Edwards, Andrew, van der Weyden, Louise, Fengtang Yang, Ramirez-Solis, Ramiro, Estabel, Jeanne, Gallagher, Ferdia A., Logan, Darren W., Arends, Mark J., Tsang, Stephen H., Mahajan, Vinit B., Scudamore, Cheryl L., and White, Jacqueline K.
- Subjects
- *
CENTROMERE , *CENTRIOLES , *IMMUNOHISTOCHEMISTRY , *MICROCEPHALY , *MITOCHONDRIA formation , *DNA damage , *MICE - Abstract
Disruption of the centromere protein J gene, CENPJ (CPAP, MCPH6, SCKL4), which is a highly conserved and ubiquitiously expressed centrosomal protein, has been associated with primary microcephaly and the microcephalic primordial dwarfism disorder Seckel syndrome. The mechanism by which disruption of CENPJ causes the proportionate, primordial growth failure that is characteristic of Seckel syndrome is unknown. By generating a hypomorphic allele of Cenpj, we have developed a mouse (Cenpjtm/tm) that recapitulates many of the clinical features of Seckel syndrome, including intrauterine dwarfism, microcephaly with memory impairment, ossification defects, and ocular and skeletal abnormalities, thus providing clear confirmation that specific mutations of CENPJ can cause Seckel syndrome. Immunohistochemistry revealed increased levels of DNA damage and apoptosis throughout Cenpjtm/tm embryos and adult mice showed an elevated frequency of micronucleus induction, suggesting that Cenpj-deficiency results in genomic instability. Notably, however, genomic instability was not the result of defective ATR-dependent DNA damage signaling, as is the case for the majority of genes associated with Seckel syndrome. Instead, Cenpjtm/tm embryonic fibroblasts exhibited irregular centriole and centrosome numbers and mono- and multipolar spindles, and many were near-tetraploid with numerical and structural chromosomal abnormalities when compared to passage-matched wild-type cells. Increased cell death due to mitotic failure during embryonic development is likely to contribute to the proportionate dwarfism that is associated with CENPJ-Seckel syndrome. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
11. Cancer gene discovery in the mouse
- Author
-
McIntyre, Rebecca E, van der Weyden, Louise, and Adams, David J
- Subjects
- *
CANCER genes , *ONCOGENES , *CARCINOGENESIS , *CROSS-species amplification , *CARCINOGENICITY , *LABORATORY mice - Abstract
Developments in high-throughput genome analysis and in computational tools have made it possible to rapidly profile entire cancer genomes with basepair resolution. In parallel with these advances, mouse models of cancer have evolved into powerful tools for cancer gene discovery. Here we discuss some of the approaches that may be used for cancer gene identification in the mouse and discuss how a cross-species ‘oncogenomics’ approach to cancer gene discovery represents a powerful strategy for finding genes that drive tumorigenesis. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
12. Rewetting and litter addition influence mineralisation and microbial communities in soils from a semi-arid intermittent stream
- Author
-
McIntyre, Rebecca E.S., Adams, Mark A., Ford, Douglas J., and Grierson, Pauline F.
- Subjects
- *
WETTING , *FOREST litter , *NUTRIENT cycles , *BACTERIAL metabolism , *PHOSPHOLIPIDS , *SOIL microbiology , *ARID regions - Abstract
Abstract: Nitrogen (N) and carbon (C) mineralisation are triggered by pulses of water availability in arid and semi-arid systems. Intermittent streams and their associated riparian communities are obvious ‘hot spots’ for biogeochemical processes in arid landscapes where water and often C are limiting. Stream landscapes are characterized by highly heterogeneous soils that may respond variably to rewetting. We used a laboratory incubation to quantify how N and C mineralisation in rewetted soils and sediments from an intermittent stream in the semi-arid Pilbara region of north-west Australia varied with saturation level and substrate addition (as ground Eucalyptus litter). Full (100%) saturation was defined as the maximum gravimetric moisture content (%) achieved in free-draining soils and sediments after rewetting, with 50% saturation defined as half this value. We estimated rates and amounts of N mineralised from changes in inorganic N and microbial respiration as CO2 efflux throughout the incubation. In soils and sediments subject to 50% saturation, >90% of N mineralised accumulated within the first 7d of incubation, compared to only 48% when soils were fully saturated (100% saturation). Mineralisation rates and microbial respiration were similar in riparian and floodplain soils, and channel sediments. N mineralisation rates in litter-amended soils and sediments (0.73mgNkg−1 d−1) were only one-third that of unamended samples (3.04mgNkg−1 d−1), while cumulative microbial respiration was doubled in litter-amended soils, suggesting N was more rapidly immobilized. Landscape position was less important in controlling microbial activity than soil saturation when water-filled pore space (% WFPS) was greater than 40%. Our results suggest that large pulses of water availability resulting in full soil saturation cause a slower release of mineralisation products, compared to small pulse events that stimulate a rapid cycle of C and N mineralisation–immobilization. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
13. Promoting the Gothic South.
- Author
-
McIntyre, Rebecca
- Subjects
- *
SWAMPS , *TRAVEL writers , *COLONISTS , *SWAMPS in art , *SWAMPS in literature - Abstract
Focuses on the swamps in the U.S. as written by travel writers. Views of colonists on swamps in the country; Image of the swamp in art and literature; Representation of the swamp in the novel "Dred: A Tale of the Great Dismal Swamp," written by Harriet Beecher Stowe.
- Published
- 2005
- Full Text
- View/download PDF
14. Somatic Evolution in Non-neoplastic IBD-Affected Colon.
- Author
-
Olafsson, Sigurgeir, McIntyre, Rebecca E., Coorens, Tim, Butler, Timothy, Jung, Hyunchul, Robinson, Philip S., Lee-Six, Henry, Sanders, Mathijs A., Arestang, Kenneth, Dawson, Claire, Tripathi, Monika, Strongili, Konstantina, Hooks, Yvette, Stratton, Michael R., Parkes, Miles, Martincorena, Inigo, Raine, Tim, Campbell, Peter J., and Anderson, Carl A.
- Subjects
- *
INFLAMMATORY bowel diseases , *COLON (Anatomy) , *INTERLEUKIN-17 , *GASTROINTESTINAL cancer , *CROHN'S disease , *SOMATIC mutation - Abstract
Inflammatory bowel disease (IBD) is a chronic inflammatory disease associated with increased risk of gastrointestinal cancers. We whole-genome sequenced 446 colonic crypts from 46 IBD patients and compared these to 412 crypts from 41 non-IBD controls from our previous publication on the mutation landscape of the normal colon. The average mutation rate of affected colonic epithelial cells is 2.4-fold that of healthy colon, and this increase is mostly driven by acceleration of mutational processes ubiquitously observed in normal colon. In contrast to the normal colon, where clonal expansions outside the confines of the crypt are rare, we observed widespread millimeter-scale clonal expansions. We discovered non-synonymous mutations in ARID1A , FBXW7 , PIGR , ZC3H12A , and genes in the interleukin 17 and Toll-like receptor pathways, under positive selection in IBD. These results suggest distinct selection mechanisms in the colitis-affected colon and that somatic mutations potentially play a causal role in IBD pathogenesis. • IBD-affected colons accrue substitutions and indels 2.4 and 7 times faster than normal • 17 signatures of mutational processes, including treatment • Millimeter-scale clonal expansions late in molecular time • Distinct mechanisms of positive selection of mutations in immune-related genes Whole-genome sequencing of inflammatory bowel disease patient samples allows insight into mutational burdens and processes associated with disease, including putative driver mutations positively selected in the diseased colon. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
15. Copy number variant detection in inbred strains from short read sequence data.
- Author
-
Simpson, Jared T., McIntyre, Rebecca E., Adams, David J., and Durbin, Richard
- Subjects
- *
ALGORITHMS , *MARKOV processes , *GENETIC polymorphisms , *GENOMICS , *CHROMOSOMES , *CHROMOSOME polymorphism - Abstract
Summary: We have developed an algorithm to detect copy number variants (CNVs) in homozygous organisms, such as inbred laboratory strains of mice, from short read sequence data. Our novel approach exploits the fact that inbred mice are homozygous at virtually every position in the genome to detect CNVs using a hidden Markov model (HMM). This HMM uses both the density of sequence reads mapped to the genome, and the rate of apparent heterozygous single nucleotide polymorphisms, to determine genomic copy number. We tested our algorithm on short read sequence data generated from re-sequencing chromosome 17 of the mouse strains A/J and CAST/EiJ with the Illumina platform. In total, we identified 118 copy number variants (43 for A/J and 75 for CAST/EiJ). We investigated the performance of our algorithm through comparison to CNVs previously identified by array-comparative genomic hybridization (array CGH). We performed quantitative-PCR validation on a subset of the calls that differed from the array CGH data sets. [ABSTRACT FROM PUBLISHER]
- Published
- 2010
- Full Text
- View/download PDF
16. Women of Discriminating Taste: White Sororities and the Making of American Ladyhood.
- Author
-
McIntyre, Rebecca Cawood
- Subjects
- *
GREEK letter societies , *WHITE women , *NONFICTION - Published
- 2022
- Full Text
- View/download PDF
17. How the New Deal Built Florida Tourism: The Civilian Conservation Corps and State Parks.
- Author
-
McIntyre, Rebecca Cawood
- Subjects
- *
PARKS , *NONFICTION - Abstract
A review of the book "How the New Deal Built Florida Tourism: The Civilian Conservation Corps and State Parks," by David J. Nelson, is presented.
- Published
- 2020
- Full Text
- View/download PDF
18. Glycine promotes longevity in Caenorhabditis elegans in a methionine cycle-dependent fashion.
- Author
-
Liu, Yasmine J., Janssens, Georges E., McIntyre, Rebecca L., Molenaars, Marte, Kamble, Rashmi, Gao, Arwen W., Jongejan, Aldo, Weeghel, Michel van, MacInnes, Alyson W., and Houtkooper, Riekelt H.
- Subjects
- *
CAENORHABDITIS , *METABOLISM , *EPIGENETICS , *EUKARYOTES , *INVERTEBRATES , *GLYCINE - Abstract
The deregulation of metabolism is a hallmark of aging. As such, changes in the expression of metabolic genes and the profiles of amino acid levels are features associated with aging animals. We previously reported that the levels of most amino acids decline with age in Caenorhabditis elegans (C. elegans). Glycine, in contrast, substantially accumulates in aging C. elegans. In this study we show that this is coupled to a decrease in gene expression of enzymes important for glycine catabolism. We further show that supplementation of glycine significantly prolongs C. elegans lifespan, and early adulthood is important for its salutary effects. Moreover, supplementation of glycine ameliorates specific transcriptional changes that are associated with aging. Glycine feeds into the methionine cycle. We find that mutations in components of this cycle, methionine synthase (metr-1) and S-adenosylmethionine synthetase (sams-1), completely abrogate glycine-induced lifespan extension. Strikingly, the beneficial effects of glycine supplementation are conserved when we supplement with serine, which also feeds into the methionine cycle. RNA-sequencing reveals a similar transcriptional landscape in serine- and glycine-supplemented worms both demarked by widespread gene repression. Taken together, these data uncover a novel role of glycine in the deceleration of aging through its function in the methionine cycle. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
19. Quantifying the contribution of recessive coding variation to developmental disorders.
- Author
-
Martin, Hilary C., Jones, Wendy D., McIntyre, Rebecca, Sanchez-Andrade, Gabriela, Sanderson, Mark, Stephenson, James D., Jones, Carla P., Handsaker, Juliet, Gallone, Giuseppe, Bruntraeger, Michaela, McRae, Jeremy F., Prigmore, Elena, Short, Patrick, Niemi, Mari, Kaplanis, Joanna, Radford, Elizabeth J., Akawi, Nadia, Balasubramanian, Meena, Dean, John, and Horton, Rachel
- Subjects
- *
DEVELOPMENTAL disabilities , *RECESSIVE genes , *GENETIC mutation , *EUROPEANS , *PAKISTANIS - Abstract
We estimated the genome-wide contribution of recessive coding variation in 6040 families from the Deciphering Developmental Disorders study. The proportion of cases attributable to recessive coding variants was 3.6% in patients of European ancestry, compared with 50% explained by de novo coding mutations. It was higher (31%) in patients with Pakistani ancestry, owing to elevated autozygosity. Half of this recessive burden is attributable to known genes. We identified two genes not previously associated with recessive developmental disorders, KDM5B and EIF3F, and functionally validated them with mouse and cellular models. Our results suggest that recessive coding variants account for a small fraction of currently undiagnosed nonconsanguineous individuals, and that the role of noncoding variants, incomplete penetrance, and polygenic mechanisms need further exploration. [ABSTRACT FROM AUTHOR]
- Published
- 2018
20. Creating Flannery O'Connor: Her Critics, Her Publishers, Her Readers.
- Author
-
McIntyre, Rebecca Cawood
- Subjects
- *
AMERICAN fiction , *NONFICTION , *LITERATURE appreciation - Published
- 2018
- Full Text
- View/download PDF
21. Gut mucosa dissociation protocols influence cell type proportions and single-cell gene expression levels.
- Author
-
Uniken Venema, Werna T. C., Ramírez-Sánchez, Aarón D., Bigaeva, Emilia, Withoff, Sebo, Jonkers, Iris, McIntyre, Rebecca E., Ghouraba, Mennatallah, Raine, Tim, Weersma, Rinse K., Franke, Lude, Festen, Eleonora A. M., and van der Wijst, Monique G. P.
- Subjects
- *
GENE expression , *MUCOUS membranes , *NEUROGLIA , *SYNTHETIC genes , *CELL survival , *MICROARRAY technology - Abstract
Single-cell RNA sequencing (scRNA-seq) has revolutionized the study of the cellular landscape of organs. Most single-cell protocols require fresh material, which limits sample size per experiment, and consequently, introduces batch effects. This is especially true for samples acquired through complex medical procedures, such as intestinal mucosal biopsies. Moreover, the tissue dissociation procedure required for obtaining single cells is a major source of noise; different dissociation procedures applied to different compartments of the tissue induce artificial gene expression differences between cell subsets. To overcome these challenges, we have developed a one-step dissociation protocol and demonstrated its use on cryopreserved gut mucosal biopsies. Using flow cytometry and scRNA-seq analysis, we compared this one-step dissociation protocol with the current gold standard, two-step collagenase digestion, and an adaptation of a recently published alternative, three-step cold-active Bacillus licheniformus protease digestion. Both cell viability and cell type composition were comparable between the one-step and two-step collagenase dissociation, with the former being more time-efficient. The cold protease digestion resulted in equal cell viability, but better preserves the epithelial cell types. Consequently, to analyze the rarer cell types, such as glial cells, larger total biopsy cell numbers are required as input material. The multi-step protocols affected cell types spanning multiple compartments differently. In summary, we show that cryopreserved gut mucosal biopsies can be used to overcome the logistical challenges and batch effects in large scRNA-seq studies. Furthermore, we demonstrate that using cryopreserved biopsies digested using a one-step collagenase protocol enables large-scale scRNA-seq, FACS, organoid generation and intraepithelial lymphocyte expansion. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
22. Gut mucosa dissociation protocols influence cell type proportions and single-cell gene expression levels.
- Author
-
Uniken Venema, Werna T. C., Ramírez-Sánchez, Aarón D., Bigaeva, Emilia, Withoff, Sebo, Jonkers, Iris, McIntyre, Rebecca E., Ghouraba, Mennatallah, Raine, Tim, Weersma, Rinse K., Franke, Lude, Festen, Eleonora A. M., and van der Wijst, Monique G. P.
- Subjects
- *
GENE expression , *MUCOUS membranes , *NEUROGLIA , *SYNTHETIC genes , *CELL survival , *MICROARRAY technology - Abstract
Single-cell RNA sequencing (scRNA-seq) has revolutionized the study of the cellular landscape of organs. Most single-cell protocols require fresh material, which limits sample size per experiment, and consequently, introduces batch effects. This is especially true for samples acquired through complex medical procedures, such as intestinal mucosal biopsies. Moreover, the tissue dissociation procedure required for obtaining single cells is a major source of noise; different dissociation procedures applied to different compartments of the tissue induce artificial gene expression differences between cell subsets. To overcome these challenges, we have developed a one-step dissociation protocol and demonstrated its use on cryopreserved gut mucosal biopsies. Using flow cytometry and scRNA-seq analysis, we compared this one-step dissociation protocol with the current gold standard, two-step collagenase digestion, and an adaptation of a recently published alternative, three-step cold-active Bacillus licheniformus protease digestion. Both cell viability and cell type composition were comparable between the one-step and two-step collagenase dissociation, with the former being more time-efficient. The cold protease digestion resulted in equal cell viability, but better preserves the epithelial cell types. Consequently, to analyze the rarer cell types, such as glial cells, larger total biopsy cell numbers are required as input material. The multi-step protocols affected cell types spanning multiple compartments differently. In summary, we show that cryopreserved gut mucosal biopsies can be used to overcome the logistical challenges and batch effects in large scRNA-seq studies. Furthermore, we demonstrate that using cryopreserved biopsies digested using a one-step collagenase protocol enables large-scale scRNA-seq, FACS, organoid generation and intraepithelial lymphocyte expansion. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
23. Livers with Constitutive mTORC1 Activity Resist Steatosis Independent of Feedback Suppression of Akt.
- Author
-
Kenerson, Heidi L., Subramanian, Savitha, McIntyre, Rebecca, Kazami, Machiko, and Yeung, Raymond S.
- Subjects
- *
FATTY liver , *MTOR protein , *PROTEIN kinase B , *PHYSIOLOGICAL control systems , *INSULIN resistance , *LIPID synthesis , *ANTIOXIDANTS - Abstract
Insulin resistance is an important contributing factor in non-alcoholic fatty liver disease. AKT and mTORC1 are key components of the insulin pathway, and play a role in promoting de novo lipogenesis. However, mTORC1 hyperactivity per se does not induce steatosis in mouse livers, but instead, protects against high-fat diet induced steatosis. Here, we investigate the in vivo mechanism of steatosis-resistance secondary to mTORC1 activation, with emphasis on the role of S6K1-mediated feedback inhibition of AKT. Mice with single or double deletion of Tsc1 and/or S6k1 in a liver-specific or whole-body manner were generated to study glucose and hepatic lipid metabolism between the ages of 6–14 weeks. Following 8 weeks of high-fat diet, the Tsc1-/-;S6k1-/- mice had lower body weights but higher liver TG levels compared to that of the Tsc1-/- mice. However, the loss of S6k1 did not relieve feedback inhibition of Akt activity in the Tsc1-/- livers. To overcome Akt suppression, Pten was deleted in Tsc1-/- livers, and the resultant mice showed improved glucose tolerance compared with the Tsc1-/- mice. However, liver TG levels were significantly reduced in the Tsc1-/-;Pten-/- mice compared to the Pten-/- mice, which was restored with rapamycin. We found no correlation between liver TG and serum NEFA levels. Expression of lipogenic genes (Srebp1c, Fasn) were elevated in the Tsc1-/-;Pten-/- livers, but this was counter-balanced by an up-regulation of Cpt1a involved in fatty acid oxidation and the anti-oxidant protein, Nrf2. In summary, our in vivo models showed that mTORC1-induced resistance to steatosis was dependent on S6K1 activity, but not secondary to AKT suppression. These findings confirm that AKT and mTORC1 have opposing effects on hepatic lipid metabolism in vivo. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
24. The Lives of Chang and Eng: Siam's Twins in Nineteenth-Century America.
- Author
-
MCINTYRE, REBECCA CAWOOD
- Subjects
- *
NONFICTION - Published
- 2016
- Full Text
- View/download PDF
25. Faith in Bikinis: Politics and Leisure in the Coastal South since the Civil War.
- Author
-
Cawood McIntyre, Rebecca
- Subjects
- *
AMERICAN Civil War, 1861-1865 , *NONFICTION - Published
- 2015
- Full Text
- View/download PDF
26. The hypermorphic PLCγ2 S707Y variant dysregulates microglial cell function – Insight into PLCγ2 activation in brain health and disease, and opportunities for therapeutic modulation.
- Author
-
Bull, Daniel, Matte, Julie C., Navarron, Carmen M., McIntyre, Rebecca, Whiting, Paul, Katan, Matilda, Ducotterd, Fiona, and Magno, Lorenza
- Subjects
- *
CELL physiology , *BRAIN diseases , *MICROGLIA , *PLURIPOTENT stem cells , *NATURAL immunity - Abstract
Phospholipase C-gamma 2 (PLCγ2) is highly expressed in hematopoietic and immune cells, where it is a key signalling node enabling diverse cellular functions. Within the periphery, gain-of-function (GOF) PLCγ2 variants, such as the strongly hypermorphic S707Y, cause severe immune dysregulation. The milder hypermorphic mutation PLCγ2 P522R increases longevity and confers protection in central nervous system (CNS) neurodegenerative disorders, implicating PLCγ2 as a novel therapeutic target for treating these CNS indications. Currently, nothing is known about what consequences strong PLCγ2 GOF has on CNS functionality, and more precisely on the specific biological functions of microglia. Using the PLCγ2 S707Y variant as a model of chronic activation we investigated the functional consequences of strong PLCγ2 GOF on human microglia. PLCγ2 S707Y expressing human inducible pluripotent stem cells (hiPSC)-derived microglia exhibited hypermorphic enzymatic activity under both basal and stimulated conditions, compared to PLCγ2 wild type. Despite the increase in PLCγ2 enzymatic activity, the PLCγ2 S707Y hiPSC-derived microglia display diminished functionality for key microglial processes including phagocytosis and cytokine secretion upon inflammatory challenge. RNA sequencing revealed a downregulation of genes related to innate immunity and response, providing molecular support for the phenotype observed. Our data suggests that chronic activation of PLCγ2 elicits a detrimental phenotype that is contributing to unfavourable CNS functions, and informs on the therapeutic window for targeting PLCγ2 in the CNS. Drug candidates targeting PLCγ2 will need to precisely mimic the effects of the PLCγ2 P522R variant on microglial function, but not those of the PLCγ2 S707Y variant. [Display omitted] • We explored the role of the strongly hypermorphic PLCγ2 S707Y variant in hiPSC-derived microglia • S707Y increased PLCγ2 enzymatic activity and intracellular calcium flux • Phagocytosis and cytokine production are diminished in PLCγ2 S707Y microglia • PLCγ2 S707Y downregulates expression of genes related to innate immunity and response • Modulation of PLCγ2 for therapy should avoid the detrimental effects of strongly hypermorphic variants like PLCγ2 S707Y [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Transcriptomic effects of rs4845604, an IBD and allergy-associated RORC variant, in stimulated ex vivo CD4+ T cells.
- Author
-
Wilson, Paul A., Santos Franco, Sara, He, Liu, Galwey, Nicholas W., Meakin, Jackie, McIntyre, Rebecca, McHugh, Simon M., Nolan, Michael A., Spain, Sarah L., Carlson, Thaddeus, Lobera, Mercedes, Rubio, Justin P., Davis, Bill, and McCarthy, Linda C.
- Subjects
- *
INFLAMMATORY bowel diseases , *GENOME-wide association studies , *TRANSCRIPTOMES , *T helper cells , *T cell differentiation , *TRAFFIC safety - Abstract
RORγt is an isoform of RORC, preferentially expressed in Th17 cells, that functions as a critical regulator of type 3 immunity. As murine Th17-driven inflammatory disease models were greatly diminished in RORC knock-out mice, this receptor was prioritised as an attractive therapeutic target for the treatment of several autoimmune diseases. Human genetic studies indicate a significant contributory role for RORC in several human disease conditions. Furthermore, genome-wide association studies (GWAS) report a significant association between inflammatory bowel disease (IBD) and the RORC regulatory variant rs4845604. To investigate if the rs4845604 variant may affect CD4+ T cell differentiation events, naïve CD4+ T cells were isolated from eighteen healthy subjects homozygous for the rs4845604 minor (A) or major (G) allele). Isolated cells from each subject were differentiated into distinct T cell lineages by culturing in either T cell maintenance medium or Th17 driving medium conditions for six days in the presence of an RORC inverse agonist (to prevent constitutive receptor activity) or an inactive diastereomer (control). Our proof of concept study indicated that genotype had no significant effect on the mean number of naïve CD4 T cells isolated, nor the frequency of Th1-like and Th17-like cells following six days of culture in any of the four culture conditions. Analysis of the derived RNA-seq count data identified genotype-driven transcriptional effects in each of the four culture conditions. Subsequent pathway enrichment analysis of these profiles reported perturbation of metabolic signalling networks, with the potential to affect the cellular detoxification response. This investigation reveals that rs4845604 genotype is associated with transcriptional effects in CD4+ T cells that may perturb immune and metabolic pathways. Most significantly, the rs4845604 GG, IBD risk associated, genotype may be associated with a differential detoxification response. This observation justifies further investigation in a larger cohort of both healthy and IBD-affected individuals. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
28. AS057 - Transcriptome and colocalisation analysis of CCR9+ gut-homing T cells and other immune cells identifies important genes and biological pathways potentiating primary sclerosing cholangitis risk.
- Author
-
Goode, Elizabeth, Panousis, Nikolaos, Fachal, Laura, Moutsianas, Loukas, Bai, Ben, McIntyre, Rebecca, Raine, Tim, Rushbrook, Simon, and Anderson, Carl
- Subjects
- *
T cells , *GENES , *CELLS , *CD28 antigen , *LIVER diseases - Published
- 2020
- Full Text
- View/download PDF
29. Mcph1-Deficient Mice Reveal a Role for MCPH1 in Otitis Media.
- Author
-
Chen, Jing, Ingham, Neil, Clare, Simon, Raisen, Claire, Vancollie, Valerie E., Ismail, Ozama, McIntyre, Rebecca E., Tsang, Stephen H., Mahajan, Vinit B., Dougan, Gordon, Adams, David J., White, Jacqueline K., and Steel, Karen P.
- Subjects
- *
OTITIS media , *ELECTROPHYSIOLOGY , *MUTAGENESIS , *PHENOTYPES , *ANIMAL genetics , *BRAIN stem , *EMBRYONIC stem cells , *LABORATORY mice - Abstract
Otitis media is a common reason for hearing loss, especially in children. Otitis media is a multifactorial disease and environmental factors, anatomic dysmorphology and genetic predisposition can all contribute to its pathogenesis. However, the reasons for the variable susceptibility to otitis media are elusive. MCPH1 mutations cause primary microcephaly in humans. So far, no hearing impairment has been reported either in the MCPH1 patients or mouse models with Mcph1 deficiency. In this study, Mcph1-deficient (Mcph1tm1a/tm1a) mice were produced using embryonic stem cells with a targeted mutation by the Sanger Institute's Mouse Genetics Project. Auditory brainstem response measurements revealed that Mcph1tm1a/tm1a mice had mild to moderate hearing impairment with around 70% penetrance. We found otitis media with effusion in the hearing-impaired Mcph1tm1a/tm1a mice by anatomic and histological examinations. Expression of Mcph1 in the epithelial cells of middle ear cavities supported its involvement in the development of otitis media. Other defects of Mcph1tm1a/tm1a mice included small skull sizes, increased micronuclei in red blood cells, increased B cells and ocular abnormalities. These findings not only recapitulated the defects found in other Mcph1-deficient mice or MCPH1 patients, but also revealed an unexpected phenotype, otitis media with hearing impairment, which suggests Mcph1 is a new gene underlying genetic predisposition to otitis media. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
30. Nuclear receptor binding protein 1 regulates intestinal progenitor cell homeostasis and tumour formation.
- Author
-
Wilson, Catherine H, Crombie, Catriona, van der Weyden, Louise, Poulogiannis, George, Rust, Alistair G, Pardo, Mercedes, Gracia, Tannia, Yu, Lu, Choudhary, Jyoti, Poulin, Gino B, McIntyre, Rebecca E, Winton, Douglas J, March, H Nikki, Arends, Mark J, Fraser, Andrew G, and Adams, David J
- Subjects
- *
NUCLEAR receptors (Biochemistry) , *CARRIER proteins , *GENETIC regulation , *PROGENITOR cells , *HOMEOSTASIS , *GENETIC testing - Abstract
Genetic screens in simple model organisms have identified many of the key components of the conserved signal transduction pathways that are oncogenic when misregulated. Here, we identify H37N21.1 as a gene that regulates vulval induction in let-60(n1046gf), a strain with a gain-of-function mutation in the Caenorhabditis elegans Ras orthologue, and show that somatic deletion of Nrbp1, the mouse orthologue of this gene, results in an intestinal progenitor cell phenotype that leads to profound changes in the proliferation and differentiation of all intestinal cell lineages. We show that Nrbp1 interacts with key components of the ubiquitination machinery and that loss of Nrbp1 in the intestine results in the accumulation of Sall4, a key mediator of stem cell fate, and of Tsc22d2. We also reveal that somatic loss of Nrbp1 results in tumourigenesis, with haematological and intestinal tumours predominating, and that nuclear receptor binding protein 1 (NRBP1) is downregulated in a range of human tumours, where low expression correlates with a poor prognosis. Thus NRBP1 is a conserved regulator of cell fate, that plays an important role in tumour suppression. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
31. The critical role of histone H2A-deubiquitinase Mysmi in hematopoiesis and lymphocyte differentiation.
- Author
-
Nijnik, Anastasia, Clare, Simon, Hale, Christine, Raisen, Claire, Mcintyre, Rebecca E., Yusa, Kosuke, Everitt, Aaron A., Mottram, Lynda, Podrini, Christine, Lucas, Mark, Estabel, Jeanne, Gouiding, David, Adams, Niels, Ramirez-Solis, Ramiro, White, Jacqui K., Adams, David J., Hancock, Robert E. W., and Dougan, Gordon
- Subjects
- *
HISTONES , *HEMATOPOIESIS , *LYMPHOCYTES , *CELL differentiation , *GENE silencing , *UBIQUITIN ligases , *LABORATORY mice , *OXIDATIVE stress , *PHYSIOLOGY - Abstract
Stem cell differentiation and lineage specification depend on coordinated programs of gene expression, but our knowledge of the chromatin-modifying factors regulating these events remains incomplete. Ubiquitination of histone H2A(H2A-K119u) is a common chromatin modification associated with gene silencing, and controlled by the ubiquitin-ligase polycomb repressor complex 1 (PRC1) and H2Adeubiquitinating enzymes (H2A-DUBs). The roles of H2A-DUBs in mammalian development, stem cells, and hematopoiesis have not been addressed. Here we characterized an H2A-DUB targeted mouse line Mysm11tm1a/tm1a and demonstrated defects in BM hematopoiesis, resulting in lymphopenia, anemia, and thrombocytosis. Development of lymphocytes was impaired from the earliest stages of their differentiation, and there was also a depletion of erythroid cells and a defect in erythroid progenitor function. These phenotypes resulted from a cell-intrinsic requirement for Mysm1 in the BM. Importantly, Mysm1tm1a/tm1a HSCs were functionally impaired, and this was associated with elevated levels of reactive oxygen species, γH2AX DNA damage marker, and p53 protein in the hematopoietic progenitors. Overall, these data establish a role for Mysmi in the maintenance of BM stem cell function, in the control of oxidative stress and genetic stability in hematopoietic progenitors, and in the development of lymphoid and erythroid lineages. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
32. Increased tumorigenesis associated with loss of the tumor suppressor gene Cadm1.
- Author
-
van der Weyden, Louise, Arends, Mark J., Rust, Alistair G., Poulogiannis, George, McIntyre, Rebecca E., and Adams, David J.
- Subjects
- *
TUMOR suppressor genes , *CARCINOGENESIS , *LYMPHOMAS , *LABORATORY mice , *CARCINOGENICITY - Abstract
Background: CADM1 encodes an immunoglobulin superfamily (IGSF) cell adhesion molecule. Inactivation of CADM11, either by promoter hypermethylation or loss of heterozygosity, has been reported in a wide variety of tumor types, thus it has been postulated as a tumor suppressor gene.Findings: We show for the first time that Cadm1 homozygous null mice die significantly faster than wildtype controls due to the spontaneous development of tumors at an earlier age and an increased tumor incidence of predominantly lymphomas, but also some solid tumors. Tumorigenesis was accelerated after irradiation of Cadm1mice, with the reduced latency in tumor formation suggesting there are genes that collaborate with loss of Cadm1in tumorigenesis. To identify these co-operating genetic events, we performed a Sleeping Beauty transposonmediatedinsertional mutagenesis screen in Cadm1 mice, and identified several common insertion sites (CIS) found specifically on a Cadm1-null background (and not wildtype background).Conclusion: We confirm that Cadm1 is indeed a bona fide tumor suppressor gene and provide new insights into genetic partners that co-operate in tumorigenesis when Cadm1-expression is lost. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
33. Disruption of mouse Slx4, a regulator of structure-specific nucleases, phenocopies Fanconi anemia.
- Author
-
Crossan, Gerry P., van der Weyden, Louise, Rosado, Ivan V., Langevin, Frederic, Gaillard, Pierre-Henri L, McIntyre, Rebecca E, Gallagher, Ferdia, Kettunen, Mikko I., Lewis, David Y., Brindle, Kevin, Arends, Mark J., Adams, David J., and Patel, Ketan J.
- Subjects
- *
ENDONUCLEASES , *FANCONI'S anemia , *DNA damage , *COMPLEMENTATION (Genetics) , *PROTEIN crosslinking , *LABORATORY mice , *GENETICS - Abstract
The evolutionarily conserved SLX4 protein, a key regulator of nucleases, is critical for DNA damage response. SLX4 nuclease complexes mediate repair during replication and can also resolve Holliday junctions formed during homologous recombination. Here we describe the phenotype of the Btbd12 knockout mouse, the mouse ortholog of SLX4, which recapitulates many key features of the human genetic illness Fanconi anemia. Btbd12-deficient animals are born at sub-Mendelian ratios, have greatly reduced fertility, are developmentally compromised and are prone to blood cytopenias. Btbd12−/− cells prematurely senesce, spontaneously accumulate damaged chromosomes and are particularly sensitive to DNA crosslinking agents. Genetic complementation reveals a crucial requirement for Btbd12 (also known as Slx4) to interact with the structure-specific endonuclease Xpf-Ercc1 to promote crosslink repair. The Btbd12 knockout mouse therefore establishes a disease model for Fanconi anemia and genetically links a regulator of nuclease incision complexes to the Fanconi anemia DNA crosslink repair pathway. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
34. Reduced nicotinamide mononucleotide is a new and potent NAD+ precursor in mammalian cells and mice.
- Author
-
Zapata-Pérez, Rubén, Tammaro, Alessandra, Schomakers, Bauke V., Scantlebery, Angelique M. L., Denis, Simone, Elfrink, Hyung L., Giroud-Gerbetant, Judith, Cantó, Carles, López-Leonardo, Carmen, McIntyre, Rebecca L., van Weeghel, Michel, Sánchez-Ferrer, Álvaro, and Houtkooper, Riekelt H.
- Abstract
Nicotinamide adenine dinucleotide (NAD+) homeostasis is constantly compromised due to degradation by NAD+-dependent enzymes. NAD+ replenishment by supplementation with the NAD+ precursors nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) can alleviate this imbalance. However, NMN and NR are limited by their mild effect on the cellular NAD+ pool and the need of high doses. Here, we report a synthesis method of a reduced form of NMN (NMNH), and identify this molecule as a new NAD+ precursor for the first time. We show that NMNH increases NAD+ levels to a much higher extent and faster than NMN or NR, and that it is metabolized through a different, NRK and NAMPT-independent, pathway. We also demonstrate that NMNH reduces damage and accelerates repair in renal tubular epithelial cells upon hypoxia/reoxygenation injury. Finally, we find that NMNH administration in mice causes a rapid and sustained NAD+ surge in whole blood, which is accompanied by increased NAD+ levels in liver, kidney, muscle, brain, brown adipose tissue, and heart, but not in white adipose tissue. Together, our data highlight NMNH as a new NAD+ precursor with therapeutic potential for acute kidney injury, confirm the existence of a novel pathway for the recycling of reduced NAD+ precursors and establish NMNH as a member of the new family of reduced NAD+ precursors. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
35. Exercise as an intervention for first‐episode psychosis: a feasibility study.
- Author
-
Firth, Joseph, Carney, Rebekah, Elliott, Rebecca, French, Paul, Parker, Sophie, Mcintyre, Rebecca, Mcphee, Jamie S., and Yung, Alison R.
- Subjects
- *
PSYCHOSES , *PSYCHIATRIC treatment , *EXERCISE & psychology , *HEALTH & psychology , *PEOPLE with schizophrenia , *SHORT-term memory - Abstract
Abstract: Aim: Exercise can improve psychiatric symptoms, neurocognitive functioning and physical health in schizophrenia. However, the effects in early psychosis have not been explored. This study aimed to assess the feasibility of an exercise intervention for early psychosis and to determine if it was associated with changes in physical and mental health. Methods: Thirty‐one patients with first‐episode psychosis (FEP) were recruited from early intervention services to a 10‐week exercise intervention. The intervention group received individualized training programmes, aiming to achieve ≥90 min of moderate‐to‐vigorous activity each week, using exercise programmes tailored to individual preferences and needs. A comparison FEP sample from the same services (n = 7) received treatment as usual. Results: Rates of consent and retention in the exercise group were 94% and 81%, respectively. Participants achieved an average of 107 min of moderate‐to‐vigorous exercise per week. Positive and Negative Syndrome Scale total scores reduced by 13.3 points after 10 weeks of exercise, which was significantly greater than the treatment as usual comparison group (P = 0.010). The greatest differences were observed in negative symptoms, which reduced by 33% in the intervention group (P = 0.013). Significant improvements were also observed in psychosocial functioning and verbal short‐term memory. Increases in cardiovascular fitness and processing speed were positively associated with the amounts of exercise achieved by participants. Conclusion: Individualized exercise training could provide a feasible treatment option for improving symptomatic, neurocognitive and metabolic outcomes in FEP. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.